5-1318385-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030782.5(CLPTM1L):c.1601C>T(p.Ala534Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000669 in 1,613,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030782.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLPTM1L | NM_030782.5 | c.1601C>T | p.Ala534Val | missense_variant | 17/17 | ENST00000320895.10 | NP_110409.2 | |
CLPTM1L | XM_011514144.3 | c.1598C>T | p.Ala533Val | missense_variant | 17/17 | XP_011512446.1 | ||
CLPTM1L | XM_024446222.2 | c.1067C>T | p.Ala356Val | missense_variant | 15/15 | XP_024301990.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 250828Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135686
GnomAD4 exome AF: 0.0000719 AC: 105AN: 1461296Hom.: 0 Cov.: 30 AF XY: 0.0000729 AC XY: 53AN XY: 726932
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.1601C>T (p.A534V) alteration is located in exon 17 (coding exon 17) of the CLPTM1L gene. This alteration results from a C to T substitution at nucleotide position 1601, causing the alanine (A) at amino acid position 534 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at